VOGENX INC

VOGX · NASDAQ

Updated at 2026-11-16 21:12:09

$14.38-13.73%
Today's High
$16.71
Today’s Low
$12.61
VOGENX INC (VOGX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$18.22
Previous Close
$16.67
Volume
94.76K
Market Cap
$247.63M
P/E Ratio
--
EPS
--

Previous Day Range

$16.18$19.24

52-Week Range

$12.95$38.41

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
BIOTECHNOLOGY
Headquarters
3901 BARRETT DRIVE, RALEIGH, NC, UNITED STATES, 27609
Country
US
Listing Date
--
Fiscal Year End
December
Shares Outstanding
14.86M
CIK
--
Website
vogenx.com

Vogenx, Inc. is a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company is headquartered in Raleigh, North Carolina.

Financial Metrics

Revenue

2026-09-30

$0

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

Operating Expenses

2026-09-30

$1.78M

2026-06-30

$355.38K

2026-03-31

$463.15K

2025-12-31

$453.78K

Net Income

2026-09-30

-$4.9M

2026-06-30

-$384.43K

2026-03-31

-$475.45K

2025-12-31

-$509.78K

Net Profit Margin

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

Earnings Per Share

2026-09-30

$-0.14

2026-06-30

$-0.07

2026-03-31

--

2025-12-31

--

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

-$1.78M

2026-06-30

-$355.38K

2026-03-31

-$463.15K

2025-12-31

-$453.78K

Effective Tax Rate

2026-09-30

--

2026-06-30

--

2026-03-31

--

2025-12-31

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.